APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medications for Alcohol Use Disorder (AUD)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Medications for Alcohol Use Disorder (AUD) Industry Growth and Trends Forecast to 2032

27 December 2025102 pages

Choose your research edition.

Industry ResearchMedications for Alcohol Use Disorder (AUD) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Medications for Alcohol Use Disorder (AUD) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Medications for Alcohol Use Disorder (AUD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medications for Alcohol Use Disorder (AUD) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Medications for Alcohol Use Disorder (AUD) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

According to APO Research, the global Medications for Alcohol Use Disorder (AUD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Medications for Alcohol Use Disorder (AUD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Medications for Alcohol Use Disorder (AUD) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medications for Alcohol Use Disorder (AUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Medications for Alcohol Use Disorder (AUD) market include Teva, Sun Pharmaceutical Industries, Merck KGaA, Mylan, Beijing Wellso Pharmaceutical Co, Zydus Pharmaceuticals, Taj Pharmaceuticals, TAGI Pharma Inc. and Rusan Pharma Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Medications for Alcohol Use Disorder (AUD) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medications for Alcohol Use Disorder (AUD) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medications for Alcohol Use Disorder (AUD) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medications for Alcohol Use Disorder (AUD).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Medications for Alcohol Use Disorder (AUD) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medications for Alcohol Use Disorder (AUD) Market by Company

Teva

Sun Pharmaceutical Industries

Merck KGaA

Mylan

Beijing Wellso Pharmaceutical Co

Zydus Pharmaceuticals

Taj Pharmaceuticals

TAGI Pharma Inc.

Rusan Pharma Ltd

Lundbeck

Glenmark Pharmaceuticals

Alvogen

Alkermes

Medications for Alcohol Use Disorder (AUD) Segment by Type

Acamprosate

Naltrexone

Disulfiram

Other

Medications for Alcohol Use Disorder (AUD) Segment by Application

Hospital

Rehabilitation Institutions

Others

Medications for Alcohol Use Disorder (AUD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medications for Alcohol Use Disorder (AUD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medications for Alcohol Use Disorder (AUD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medications for Alcohol Use Disorder (AUD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Medications for Alcohol Use Disorder (AUD) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Medications for Alcohol Use Disorder (AUD) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2021-2026) Table 4. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2027-2032) Table 6. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Medications for Alcohol Use Disorder (AUD) Market Size Share by Type (2021-2026) Table 9. Global Medications for Alcohol Use Disorder (AUD) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Medications for Alcohol Use Disorder (AUD) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Medications for Alcohol Use Disorder (AUD) Market Size Share by Application (2021-2026) Table 24. Global Medications for Alcohol Use Disorder (AUD) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Medications for Alcohol Use Disorder (AUD) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Medications for Alcohol Use Disorder (AUD) Industry Trends Table 37. Medications for Alcohol Use Disorder (AUD) Industry Drivers Table 38. Medications for Alcohol Use Disorder (AUD) Industry Opportunities and Challenges Table 39. Medications for Alcohol Use Disorder (AUD) Industry Restraints Table 40. Global Medications for Alcohol Use Disorder (AUD) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Company (2021-2026) Table 42. Global Medications for Alcohol Use Disorder (AUD) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Medications for Alcohol Use Disorder (AUD) Key Company Headquarters & Area Served Table 44. Global Medications for Alcohol Use Disorder (AUD) Company, Product Type & Application Table 45. Global Medications for Alcohol Use Disorder (AUD) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Medications for Alcohol Use Disorder (AUD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Teva Company Information Table 49. Teva Business Overview Table 50. Teva Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Teva Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 52. Teva Recent Development Table 53. Sun Pharmaceutical Industries Company Information Table 54. Sun Pharmaceutical Industries Business Overview Table 55. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 57. Sun Pharmaceutical Industries Recent Development Table 58. Merck KGaA Company Information Table 59. Merck KGaA Business Overview Table 60. Merck KGaA Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Merck KGaA Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 62. Merck KGaA Recent Development Table 63. Mylan Company Information Table 64. Mylan Business Overview Table 65. Mylan Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Mylan Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 67. Mylan Recent Development Table 68. Beijing Wellso Pharmaceutical Co Company Information Table 69. Beijing Wellso Pharmaceutical Co Business Overview Table 70. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 72. Beijing Wellso Pharmaceutical Co Recent Development Table 73. Zydus Pharmaceuticals Company Information Table 74. Zydus Pharmaceuticals Business Overview Table 75. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 77. Zydus Pharmaceuticals Recent Development Table 78. Taj Pharmaceuticals Company Information Table 79. Taj Pharmaceuticals Business Overview Table 80. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 82. Taj Pharmaceuticals Recent Development Table 83. TAGI Pharma Inc. Company Information Table 84. TAGI Pharma Inc. Business Overview Table 85. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 87. TAGI Pharma Inc. Recent Development Table 88. Rusan Pharma Ltd Company Information Table 89. Rusan Pharma Ltd Business Overview Table 90. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 92. Rusan Pharma Ltd Recent Development Table 93. Lundbeck Company Information Table 94. Lundbeck Business Overview Table 95. Lundbeck Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Lundbeck Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 97. Lundbeck Recent Development Table 98. Glenmark Pharmaceuticals Company Information Table 99. Glenmark Pharmaceuticals Business Overview Table 100. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 102. Glenmark Pharmaceuticals Recent Development Table 103. Alvogen Company Information Table 104. Alvogen Business Overview Table 105. Alvogen Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Alvogen Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 107. Alvogen Recent Development Table 108. Alkermes Company Information Table 109. Alkermes Business Overview Table 110. Alkermes Medications for Alcohol Use Disorder (AUD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Alkermes Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 112. Alkermes Recent Development Table 113. North America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2026) Table 116. North America Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Medications for Alcohol Use Disorder (AUD) Market Share Forecast by Country (2027-2032) Table 118. Europe Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2026) Table 121. Europe Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Medications for Alcohol Use Disorder (AUD) Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2026) Table 126. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Share Forecast by Country (2027-2032) Table 128. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2026) Table 131. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Medications for Alcohol Use Disorder (AUD) Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2026) Table 136. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Medications for Alcohol Use Disorder (AUD) Product Image Figure 3. Global Medications for Alcohol Use Disorder (AUD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 5. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region: 2025 VS 2032 Figure 6. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2021-2032) Figure 7. North America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Acamprosate Image Figure 13. Global Acamprosate Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Naltrexone Image Figure 15. Global Naltrexone Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Disulfiram Image Figure 17. Global Disulfiram Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Medications for Alcohol Use Disorder (AUD) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Medications for Alcohol Use Disorder (AUD) Market Share by Type 2025 VS 2032 Figure 22. North America Medications for Alcohol Use Disorder (AUD) Market Size Share by Type (2021-2032) Figure 23. Europe Medications for Alcohol Use Disorder (AUD) Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Share by Type (2021-2032) Figure 25. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Medications for Alcohol Use Disorder (AUD) Market Size Share by Type (2021-2032) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Rehabilitation Institutions Image Figure 30. Global Rehabilitation Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Medications for Alcohol Use Disorder (AUD) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Medications for Alcohol Use Disorder (AUD) Market Share by Application 2025 VS 2032 Figure 35. North America Medications for Alcohol Use Disorder (AUD) Market Size Share by Application (2021-2032) Figure 36. Europe Medications for Alcohol Use Disorder (AUD) Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Share by Application (2021-2032) Figure 38. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Medications for Alcohol Use Disorder (AUD) Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Medications for Alcohol Use Disorder (AUD) Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Medications for Alcohol Use Disorder (AUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032) Figure 45. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032) Figure 48. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032) Figure 51. Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032) Figure 54. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Acamprosate
  • Naltrexone
  • Disulfiram
  • Other
Applications
  • Hospital
  • Rehabilitation Institutions
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical Industries
  • Merck KGaA
  • Mylan
  • Beijing Wellso Pharmaceutical Co
  • Zydus Pharmaceuticals
  • Taj Pharmaceuticals
  • TAGI Pharma Inc.
  • Rusan Pharma Ltd
  • Lundbeck
  • Glenmark Pharmaceuticals
  • Alvogen
  • Alkermes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Medications for Alcohol Use Disorder (AUD) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2032)
  5. 1.4.1 Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026)
  6. 1.4.2 Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032)
  8. 1.5.1 North America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032)
2 Medications for Alcohol Use Disorder (AUD) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Acamprosate
  3. 2.1.2 Naltrexone
  4. 2.1.3 Disulfiram
  5. 2.1.4 Other
  6. 2.2 Global Medications for Alcohol Use Disorder (AUD) Market Size by Type
  7. 2.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Medications for Alcohol Use Disorder (AUD) Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Medications for Alcohol Use Disorder (AUD) Market Size by Regions
  11. 2.3.1 North America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Type (2021-2026)
3 Medications for Alcohol Use Disorder (AUD) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Rehabilitation Institutions
  4. 3.1.3 Others
  5. 3.2 Global Medications for Alcohol Use Disorder (AUD) Market Size by Application
  6. 3.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Medications for Alcohol Use Disorder (AUD) Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Medications for Alcohol Use Disorder (AUD) Market Size by Regions
  10. 3.3.1 North America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Medications for Alcohol Use Disorder (AUD) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Medications for Alcohol Use Disorder (AUD) Industry Trends
  2. 4.2 Medications for Alcohol Use Disorder (AUD) Industry Drivers
  3. 4.3 Medications for Alcohol Use Disorder (AUD) Industry Opportunities and Challenges
  4. 4.4 Medications for Alcohol Use Disorder (AUD) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Medications for Alcohol Use Disorder (AUD) Revenue (2021-2026)
  2. 5.2 Global Medications for Alcohol Use Disorder (AUD) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Medications for Alcohol Use Disorder (AUD) Key Company Headquarters & Area Served
  4. 5.4 Global Medications for Alcohol Use Disorder (AUD) Company, Product Type & Application
  5. 5.5 Global Medications for Alcohol Use Disorder (AUD) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Medications for Alcohol Use Disorder (AUD) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Medications for Alcohol Use Disorder (AUD) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Medications for Alcohol Use Disorder (AUD) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Teva Medications for Alcohol Use Disorder (AUD) Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharmaceutical Industries
  8. 6.2.1 Sun Pharmaceutical Industries Company Information
  9. 6.2.2 Sun Pharmaceutical Industries Business Overview
  10. 6.2.3 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Industries Recent Developments
  13. 6.3 Merck KGaA
  14. 6.3.1 Merck KGaA Company Information
  15. 6.3.2 Merck KGaA Business Overview
  16. 6.3.3 Merck KGaA Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Merck KGaA Medications for Alcohol Use Disorder (AUD) Product Portfolio
  18. 6.3.5 Merck KGaA Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Medications for Alcohol Use Disorder (AUD) Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Beijing Wellso Pharmaceutical Co
  26. 6.5.1 Beijing Wellso Pharmaceutical Co Company Information
  27. 6.5.2 Beijing Wellso Pharmaceutical Co Business Overview
  28. 6.5.3 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product Portfolio
  30. 6.5.5 Beijing Wellso Pharmaceutical Co Recent Developments
  31. 6.6 Zydus Pharmaceuticals
  32. 6.6.1 Zydus Pharmaceuticals Company Information
  33. 6.6.2 Zydus Pharmaceuticals Business Overview
  34. 6.6.3 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio
  36. 6.6.5 Zydus Pharmaceuticals Recent Developments
  37. 6.7 Taj Pharmaceuticals
  38. 6.7.1 Taj Pharmaceuticals Company Information
  39. 6.7.2 Taj Pharmaceuticals Business Overview
  40. 6.7.3 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio
  42. 6.7.5 Taj Pharmaceuticals Recent Developments
  43. 6.8 TAGI Pharma Inc.
  44. 6.8.1 TAGI Pharma Inc. Company Information
  45. 6.8.2 TAGI Pharma Inc. Business Overview
  46. 6.8.3 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product Portfolio
  48. 6.8.5 TAGI Pharma Inc. Recent Developments
  49. 6.9 Rusan Pharma Ltd
  50. 6.9.1 Rusan Pharma Ltd Company Information
  51. 6.9.2 Rusan Pharma Ltd Business Overview
  52. 6.9.3 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product Portfolio
  54. 6.9.5 Rusan Pharma Ltd Recent Developments
  55. 6.10 Lundbeck
  56. 6.10.1 Lundbeck Company Information
  57. 6.10.2 Lundbeck Business Overview
  58. 6.10.3 Lundbeck Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Lundbeck Medications for Alcohol Use Disorder (AUD) Product Portfolio
  60. 6.10.5 Lundbeck Recent Developments
  61. 6.11 Glenmark Pharmaceuticals
  62. 6.11.1 Glenmark Pharmaceuticals Company Information
  63. 6.11.2 Glenmark Pharmaceuticals Business Overview
  64. 6.11.3 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio
  66. 6.11.5 Glenmark Pharmaceuticals Recent Developments
  67. 6.12 Alvogen
  68. 6.12.1 Alvogen Company Information
  69. 6.12.2 Alvogen Business Overview
  70. 6.12.3 Alvogen Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Alvogen Medications for Alcohol Use Disorder (AUD) Product Portfolio
  72. 6.12.5 Alvogen Recent Developments
  73. 6.13 Alkermes
  74. 6.13.1 Alkermes Company Information
  75. 6.13.2 Alkermes Business Overview
  76. 6.13.3 Alkermes Medications for Alcohol Use Disorder (AUD) Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Alkermes Medications for Alcohol Use Disorder (AUD) Product Portfolio
  78. 6.13.5 Alkermes Recent Developments
7 North America
  1. 7.1 North America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
  3. 7.3 North America Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
  3. 8.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
  3. 10.3 South America Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst